Cargando…
Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study [Corrigendum]
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6276818/ https://www.ncbi.nlm.nih.gov/pubmed/30568511 http://dx.doi.org/10.2147/CLEP.S191335 |
Ejemplares similares
-
Assessment of channeling bias among initiators of glucose-lowering drugs: A UK cohort study
por: Ankarfeldt, Mikkel Z, et al.
Publicado: (2017) -
Corrigendum to: Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: A nationwide registry analysis
Publicado: (2023) -
Corrigendum to: Intraspecific Transcriptome Variation and Sex-Biased Expression in Anopheles Arabiensis
por: Jayaswal, Vivek, et al.
Publicado: (2022) -
Corrigendum to: Neural evidence for persistent attentional bias to threats in patients with social anxiety disorder
por: Kim, So-Yeon, et al.
Publicado: (2018) -
Corrigendum to “Cholesterol-Lowering Probiotics as Potential Biotherapeutics for Metabolic Diseases”
por: Kumar, Manoj, et al.
Publicado: (2022)